Premas Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 12-07-2024
- Paid Up Capital ₹ 28.73 Cr
as on 12-07-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 77.00 Cr
as on 12-07-2024
- Revenue 94.44%
(FY 2022)
- Profit 164.36%
(FY 2022)
- Ebitda 166.40%
(FY 2022)
- Net Worth 112.69%
(FY 2022)
- Total Assets 94.81%
(FY 2022)
About Premas Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 28.73 Cr.
The company currently has active open charges totaling ₹77.00 Cr.
The Key Managerial Personnel (KMP) at Premas Life Sciences Private Limited India are Ashok Jain as CFO and Ritika Mundra as Company Secretary. Debjit Patra, Avijit Das, and Praveen Gupta serve as directors at the Company.
- CIN/LLPIN
U51909DL2011PTC217592
- Company No.
217592
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2011
- Date of AGM
07 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Premas Life Sciences Private Limited offer?
Premas Life Sciences Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Premas Life Sciences?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Praveen Gupta | Managing Director | 15-Apr-2011 | Current |
Ashok Jain | CFO | 09-Sep-2022 | Current |
Ritika Mundra | Company Secretary | 16-Feb-2023 | Current |
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Debjit Patra | Director | 20-Mar-2016 | Current |
Avijit Das | Director | 15-Apr-2011 | Current |
Financial Performance and Corporate Structure Insights of Premas Life Sciences.
Premas Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 94.44% increase. The company also saw a substantial improvement in profitability, with a 164.36% increase in profit. The company's net worth Soared by an impressive increase of 112.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Premas Life Sciences?
In 2022, Premas Life Sciences had a promoter holding of 93.12% and a public holding of 6.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Paramount Polish Processors Private Limited.Active 24 years 2 months
Debjit Patra is a mutual person
- Db Manufacturers And Processors Private LimitedActive 4 years 9 months
Debjit Patra is a mutual person
- Futureprep Consulting Ai Private LimitedInactive For E-Filing 3 months 23 days
Debjit Patra is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 22 Dec 2021 | ₹27.00 Cr | Open |
Hdfc Bank Limited Creation Date: 29 Nov 2021 | ₹25.00 Cr | Open |
Citi Bank N.A. Creation Date: 14 Mar 2019 | ₹25.00 Cr | Open |
How Many Employees Work at Premas Life Sciences?
Premas Life Sciences has a workforce of 88 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Premas Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premas Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.